[Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
14-Hydroxy-3beta-[4-O-methyl-alpha-L-rhamnopyranosyl)oxy]-14beta-bufa-4,20,22-trienolide (meproscillarin) is a new semisynthetic glycoside for the therapy of cardiac insufficiency. The preparation from proscillaridin and the chemical and physical properties are described.
D002018:Bufanolides / Q000032:analysis / Q000138:chemical synthesis*; D002301:Cardiac Glycosides / Q000032:analysis / Q000138:chemical synthesis*; D055598:Chemical Phenomena; D002621:Chemistry; D008722:Methods; D011442:Proscillaridin
D002018:Bufanolides; D002301:Cardiac Glycosides; D011442:Proscillaridin
Meproscillarin, ein neues halbsynthetisches Herzglykosid. Chemie und physikalische Eigenschaften.